Alibaba Health Information Technology Limited Alibaba Health Information Technology Limited

Alibaba Health Information Technology Limited

0241

Classement en actions #3021
Alibaba Health Information Technology Limited, an investment holding company,... Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, healthcare food, adult and family planning products, and various other health-related products. It also provides medical and healthcare services, including medical checkups, medical consultation, appointment-booking, vaccination, dental and mental care, optometry, and nursing services, as well as traditional chinese medicines. The company provides products and services to business-to-customer and business-to-business customers through offline pharmacy outlets, as well as online stores, such as Tmall, Taobao, Alipay, Ele.me, AMap, DingTalk, Freshippo, and Quark. In addition, it engages in the digital tracking business; asset management; network hospital, software technical services, healthcare related internet information and technical services and research; operation of internet hospitals, as well as Alibaba Health, flagship platform of Alibaba Group for integrated online and offline medical and healthcare resources, providing one-stop healthcare solutions. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. Alibaba Health Information Technology Limited was incorporated in 1998 and is based in Causeway Bay, Hong Kong.
Prix de l'action
$0.37403831
Capitalisation boursière
$6.05B
Changement (1 jour)
-4.14%
Changement (1 an)
-52.58%
Pays
HK
Échange Alibaba Health Information Technology Limited (0241)

Catégorie

Healthcare
Ratio P/S pour Alibaba Health Information Technology Limited (0241)
Ratio P/S au October 2026 TTM : 1.17
Selon les derniers rapports financiers et le cours de l'action de Alibaba Health Information Technology Limited, le ratio cours/ventes actuel (TTM) est 1.17. À la fin de 2024, le ratio P/S était de 1.48.
Historique du ratio P/S pour Alibaba Health Information Technology Limited de 2004 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
2026 (TTM) 1.17 -49.39%
2025 2.31 56.01%
2024 1.48 -41.01%
2023 2.51 -6.95%
2022 2.69 -82.98%
2021 15.82 7.50%
2020 14.72 -9.90%
2019 16.33 39.36%
2018 11.72 -78.03%
2017 53.36 -90.61%
2016 568.02 -60.08%
2015 1.42K 303.61%
2014 352.52 10,489.26%
2013 3.33 -9.99%
2012 3.70 -66.85%
2011 11.16 -50.58%
2010 22.58 1,109.49%
2009 1.87 -76.76%
2008 8.03 -22.91%
2007 10.42 14.13%
2006 9.13 -80.34%
2005 46.43 134.60%
2004 19.79 0.00%
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
1.53 30.68%
US
65.30 5,485.81%
AU
0.87 -25.40%
US
8.37 615.74%
US
15.04 1,186.76%
US